Wound Healing Research Group, Department of Surgery, University of Alberta, WMC 2D2.28, 8440-112 Street, Edmonton AB, Canada, T6G 2B7.
J Cell Commun Signal. 2013 Dec;7(4):239-52. doi: 10.1007/s12079-013-0195-5. Epub 2013 Mar 18.
Hypertrophic scar (HTS) is a dermal form of fibroproliferative disorder which often develops after thermal or traumatic injury to the deep regions of the skin and is characterized by excessive deposition and alterations in morphology of collagen and other extracellular matrix (ECM) proteins. HTS are cosmetically disfiguring and can cause functional problems that often recur despite surgical attempts to remove or improve the scars. In this review, the roles of various fibrotic and anti-fibrotic molecules are discussed in order to improve our understanding of the molecular mechanism of the pathogenesis of HTS. These molecules include growth factors, cytokines, ECM molecules, and proteolytic enzymes. By exploring the mechanisms of this form of dermal fibrosis, we seek to provide some insight into this form of dermal fibrosis that may allow clinicians to improve treatment and prevention in the future.
增生性瘢痕(HTS)是一种皮肤纤维化疾病,通常发生在皮肤深部受到热或创伤后,其特征是胶原和其他细胞外基质(ECM)蛋白的过度沉积和形态改变。HTS 会影响外观美观,并导致功能问题,尽管尝试通过手术去除或改善疤痕,但这些问题经常复发。在这篇综述中,讨论了各种纤维化和抗纤维化分子的作用,以增进我们对 HTS 发病机制的分子机制的理解。这些分子包括生长因子、细胞因子、细胞外基质分子和蛋白水解酶。通过探索这种形式的皮肤纤维化的机制,我们试图提供一些对此种形式的皮肤纤维化的深入了解,这可能使临床医生能够在未来改善治疗和预防。